Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Aspira Women's Health Inc.
Report date June 04, 2025 · Filed June 06, 2025
Section 16 reporting ended · disclosed 2025-06-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 134,734 |
Reported balance
After 2025-06-04 transaction · row 1
1 source rowRow 1 · 2025-06-04 · Exercise / conversion · Acquired 4,844 · Balance 134,734 F1: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-06-04 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-06-04 · Exercise / conversion · Disposed 4,844 · Balance 0 F2: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024.
F2: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
F3: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2025 Filed Jun 6, 2025 11:53 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-013935 · ownership.xml · derivative · entry 2 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,844 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. The common stock into which such vested RSUs converted on June 4, 2025 is reported in Table I on this Form 4. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 11:53 UTC | Aspira Women's Health Inc. AWHL · Entity 7871 | Exercise / conversionCommon Stock | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-013935 · ownership.xml · nonDerivative · entry 1 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on June 4, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 22:42 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 4,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-002183 · ownership.xml · derivative · entry 2 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,844 Underlying: Common Stock · 4,843 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 22:42 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionCommon Stock | 4,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-002183 · ownership.xml · nonDerivative · entry 1 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,843 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| December 31, 2024 Filed Jan 8, 2025 23:47 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0002031593-25-000001 · primary_doc.xml · derivative · entry 2 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,687 Underlying: Common Stock · 4,844 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4. Read SEC document |
| December 31, 2024 Filed Jan 8, 2025 23:47 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionCommon Stock | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0002031593-25-000001 · primary_doc.xml · nonDerivative · entry 1 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,047 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:31 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0002031593-24-000001 · primary_doc.xml · derivative · entry 2 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,531 Underlying: Common Stock · 4,844 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:31 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionCommon Stock | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0002031593-24-000001 · primary_doc.xml · nonDerivative · entry 1 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| September 30, 2024 Filed Nov 22, 2024 23:16 UTC Amendment | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionRestricted Stock Units · Derivative | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0002031593-24-000002 · primary_doc.xml · derivative · entry 2 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,531 Underlying: Common stock · 4,844 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock. F4 · kind: This report is being filed to correct the derivative securities from acquired to disposed. F3 · derivative.exercise_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4. F3 · derivative.expiration_date: On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. The common stock into which such vested RSUs converted on September 30, 2024 is reported in Table I on this Form 4. Read SEC document |
| September 30, 2024 Filed Nov 22, 2024 23:16 UTC Amendment | Aspira Women's Health Inc. AWH · Entity 7871 | Exercise / conversionCommon Stock | 4,844 | $0.00 | $0.00 |
DisclosureSEC source: 0002031593-24-000002 · primary_doc.xml · nonDerivative · entry 1 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,203 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On August 22, 2024, the reporting person was granted 19,375 RSUs, 4,844 of which vested on September 30, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on August 26, 2024. Read SEC document |
| August 22, 2024 Filed Aug 26, 2024 11:25 UTC | Aspira Women's Health Inc. AWH · Entity 7871 | GrantRestricted Stock Units · Derivative | 19,375 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-100346 · ownership.xml · derivative · entry 1 Ragard John Phillip · CIK 0002031593 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,375 Underlying: Common Stock · 19,375 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. F2 · derivative.expiration_date: The award will vest in four substantially equal installments on September 30, 2024, December 31, 2024, March 31, 2025 and the date of the annual shareholders' meeting, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.